Leslie D. Funtleyder - Oct 1, 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role
Chief Financial Officer, Director
Signature
/s/ Leslie D. Funtleyder
Stock symbol
APLT
Transactions as of
Oct 1, 2025
Transactions value $
$0
Form type
4
Date filed
10/1/2025, 06:28 PM
Previous filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Funtleyder Leslie D. Chief Financial Officer, Director C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK /s/ Leslie D. Funtleyder 2025-10-01 0001775394

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +150K +14.42% $0.00 1.19M Oct 1, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following October 1, 2025, subject to the Reporting Person continuing to provide services through each such date.
F2 The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the understatement of the total holdings.